Canine Influenza Vaccine Industry: Global Vaccine Demand Rises as Canine Influenza Spreads Across Continents The rising Global Canine Influenza Vaccine t has intensified competition among large vaccine producers to launch vaccines providing cross-protection. Zoetis, one of the top animal health companies, has several experimental vaccines in late-stage clinical trials. Merial, now part of Boehringer Ingelheim after a 2017 merger, has two separate intranasal vaccines nearing registration. The H3N2 product performed very well in field studies conducted in Korea and Thailand, completely preventing lung lesions. In an earnings call, Merial's Chief Scientific Officer Dr. Christine Lang stated "The rapid globalization of canine influenza virus poses an urgent public health issue. Get More Insights: Global Canine Influenza Vaccine (https://www.trendingwebwire.com/canine-influenza-vaccine-market-analysis/ )